CROWN ADVISORS MANAGEMENT, INC. Poseida Therapeutics, Inc. Transaction History

CROWN ADVISORS MANAGEMENT, INC. portfolio value:

$529,000
portfolio value

Poseida Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 150K shares 529K $3.53 150K